These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 20512795

  • 1. Inhibition studies of Mycobacterium tuberculosis salicylate synthase (MbtI).
    Manos-Turvey A, Bulloch EM, Rutledge PJ, Baker EN, Lott JS, Payne RJ.
    ChemMedChem; 2010 Jul 05; 5(7):1067-79. PubMed ID: 20512795
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Structure and mechanism of MbtI, the salicylate synthase from Mycobacterium tuberculosis.
    Zwahlen J, Kolappan S, Zhou R, Kisker C, Tonge PJ.
    Biochemistry; 2007 Jan 30; 46(4):954-64. PubMed ID: 17240979
    [Abstract] [Full Text] [Related]

  • 4. Implications of binding mode and active site flexibility for inhibitor potency against the salicylate synthase from Mycobacterium tuberculosis.
    Chi G, Manos-Turvey A, O'Connor PD, Johnston JM, Evans GL, Baker EN, Payne RJ, Lott JS, Bulloch EM.
    Biochemistry; 2012 Jun 19; 51(24):4868-79. PubMed ID: 22607697
    [Abstract] [Full Text] [Related]

  • 5. New Chromane-Based Derivatives as Inhibitors of Mycobacterium tuberculosis Salicylate Synthase (MbtI): Preliminary Biological Evaluation and Molecular Modeling Studies.
    Pini E, Poli G, Tuccinardi T, Chiarelli LR, Mori M, Gelain A, Costantino L, Villa S, Meneghetti F, Barlocco D.
    Molecules; 2018 Jun 21; 23(7):. PubMed ID: 29933627
    [Abstract] [Full Text] [Related]

  • 6. Inhibitors of the salicylate synthase (MbtI) from Mycobacterium tuberculosis discovered by high-throughput screening.
    Vasan M, Neres J, Williams J, Wilson DJ, Teitelbaum AM, Remmel RP, Aldrich CC.
    ChemMedChem; 2010 Dec 03; 5(12):2079-87. PubMed ID: 21053346
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The structure of MbtI from Mycobacterium tuberculosis, the first enzyme in the biosynthesis of the siderophore mycobactin, reveals it to be a salicylate synthase.
    Harrison AJ, Yu M, Gårdenborg T, Middleditch M, Ramsay RJ, Baker EN, Lott JS.
    J Bacteriol; 2006 Sep 03; 188(17):6081-91. PubMed ID: 16923875
    [Abstract] [Full Text] [Related]

  • 9. Elucidation of Mycobacterium tuberculosis type II dehydroquinase inhibitors using a fragment elaboration strategy.
    Tran AT, West NP, Britton WJ, Payne RJ.
    ChemMedChem; 2012 Jun 03; 7(6):1031-43. PubMed ID: 22461418
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Inhibition of chorismate-utilising enzymes by 2-amino-4-carboxypyridine and 4-carboxypyridone and 5-carboxypyridone analogues.
    Payne RJ, Bulloch EM, Kerbarh O, Abell C.
    Org Biomol Chem; 2010 Aug 07; 8(15):3534-42. PubMed ID: 20532401
    [Abstract] [Full Text] [Related]

  • 12. New insight into structure-activity of furan-based salicylate synthase (MbtI) inhibitors as potential antitubercular agents.
    Chiarelli LR, Mori M, Beretta G, Gelain A, Pini E, Sammartino JC, Stelitano G, Barlocco D, Costantino L, Lapillo M, Poli G, Caligiuri I, Rizzolio F, Bellinzoni M, Tuccinardi T, Villa S, Meneghetti F.
    J Enzyme Inhib Med Chem; 2019 Dec 07; 34(1):823-828. PubMed ID: 30889995
    [Abstract] [Full Text] [Related]

  • 13. Integration of ligand and structure based approaches for identification of novel MbtI inhibitors in Mycobacterium tuberculosis and molecular dynamics simulation studies.
    Maganti L, Grandhi P, Ghoshal N.
    J Mol Graph Model; 2016 Nov 07; 70():14-22. PubMed ID: 27639087
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Ligand based virtual screening and biological evaluation of inhibitors of chorismate mutase (Rv1885c) from Mycobacterium tuberculosis H37Rv.
    Agrawal H, Kumar A, Bal NC, Siddiqi MI, Arora A.
    Bioorg Med Chem Lett; 2007 Jun 01; 17(11):3053-8. PubMed ID: 17418569
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Understanding the different activities of highly promiscuous MbtI by computational methods.
    Ferrer S, Martí S, Moliner V, Tuñón I, Bertrán J.
    Phys Chem Chem Phys; 2012 Mar 14; 14(10):3482-9. PubMed ID: 22307014
    [Abstract] [Full Text] [Related]

  • 19. Synthesis and biological activities of triazole derivatives as inhibitors of InhA and antituberculosis agents.
    Menendez C, Gau S, Lherbet C, Rodriguez F, Inard C, Pasca MR, Baltas M.
    Eur J Med Chem; 2011 Nov 14; 46(11):5524-31. PubMed ID: 21944473
    [Abstract] [Full Text] [Related]

  • 20. Functionalized 3-amino-imidazo[1,2-a]pyridines: a novel class of drug-like Mycobacterium tuberculosis glutamine synthetase inhibitors.
    Odell LR, Nilsson MT, Gising J, Lagerlund O, Muthas D, Nordqvist A, Karlén A, Larhed M.
    Bioorg Med Chem Lett; 2009 Aug 15; 19(16):4790-3. PubMed ID: 19560924
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.